In addition, the downregulation of phosphoinositide 3-kinase/AKT activity in non-small cell lung cancer cells leads to the instability of ANLN and induces a reduction in the ANLN level in the nucleus [29]. The gene discussed is ANLN; the disease is non-small cell lung carcinoma.